HighTower Advisors LLC increased its stake in Merck & Co., Inc. (NYSE:MRK) by 2.6% in the third quarter, holding over 3.8 million shares valued at approximately $324.7 million. Institutional investors now own about 76.07% of MRK. Despite recent insider sales totaling over $38 million, analysts maintain a “Moderate Buy” consensus with an average price target of $123.71, and Merck recently announced a quarterly dividend of $0.85 per share.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Merck & Co., Inc. $MRK Shares Bought by HighTower Advisors LLC
HighTower Advisors LLC increased its stake in Merck & Co., Inc. (NYSE:MRK) by 2.6% in the third quarter, holding over 3.8 million shares valued at approximately $324.7 million. Institutional investors now own about 76.07% of MRK. Despite recent insider sales totaling over $38 million, analysts maintain a “Moderate Buy” consensus with an average price target of $123.71, and Merck recently announced a quarterly dividend of $0.85 per share.